| Group | 0D | 6D | 12D | 18D | 24D | 30D | 36D | 42D |
| A | 79.06 ± 11.88 | 84.70 ± 20.02 | 66.45 ± 9.115 | 91.77 ± 11.27 | 122.9 ± 31.84 | 73.16 ± 12.32 | 61.99 ± 10.06 | 61.48 ± 10.08 | B | 84.12 ± 8.411 | 176.4 ± 36.61*** | 165.4 ± 27.44** | 262.6 ± 45.02*** | 359.9 ± 61.90*** | 296.0 ± 80.12*** | 290.8 ± 66.87*** | 290.1 ± 46.93*** | C | 83.40 ± 18.30 | 159.2 ± 26.99*** | 184.6 ± 84.74*** | 261.7 ± 41.11*** | 360.2 ± 84.24*** | 294.5 ± 111.8*** | 328.8 ± 126.5*** | 239.7 ± 69.45*** | D | 85.43 ± 18.49 | 161.2 ± 56.09*** | 194.6 ± 26.80***, # | 257.0 ± 32.58*** | 247.3 ± 54.32***, ### | 244.8 ± 41.50*** | 192.8 ± 33.40***, ## | 227.3 ± 39.93***, # | E | 80.97 ± 8.531 | 178.7 ± 42.40*** | 187.5 ± 55.53*** | 255.1 ± 27.57*** | 247.8 ± 74.33***, ## | 221.8 ± 54.88***, # | 198.2 ± 45.39***, ## | 227.6 ± 28.22***, ## | F | 89.7 ± 10.92* | 143.4 ± 30.45***, # | 168.0 ± 28.74*** | 291.8 ± 72.83*** | 232.1 ± 95.54**, ##,†† | 209.0 ± 57.89***, # | 182.8 ± 47.29***, ##,†† | 212.3 ± 43.93***, ## | G | 88.61 ± 20.01 | 140.3 ± 26.14***, # | 209.8 ± 54.84***, # | 293.4 ± 47.51***,† | 227.2 ± 57.10***, ### | 216.3 ± 47.35***, # | 186.9 ± 104.9***, # | 188.0 ± 50.93***, ### | H | 90.65 ± 26.83 | 244.4 ± 87.23***, #,† | 211.1 ± 33.37***, ## | 296.5 ± 73.34*** | 237.5 ± 44.76***, ### | 219.9 ± 58.06***, # | 262.6 ± 60.32***,† | 299.4 ± 70.86***,† | I | 82.85 ± 7.949 | 183.6 ± 55.04*** | 227.7 ± 42.07***, ### | 274.7 ± 60.25*** | 235.5 ± 63.81***, ### | 238.4 ± 82.48*** | 239.5 ± 43.00*** | 263.3 ± 53.51*** | J | 78.25 ± 10.91 | 134.6 ± 17.74***, ## | 160.9 ± 22.66*** | 237.9 ± 32.93*** | 243.7 ± 40.02***, ### | 259.5 ± 61.93*** | 237.4 ± 91.13*** | 250.9 ± 34.42*** |
|
|
Total cholesterol (TC) contents were assayed by assay kits as described in the text. Values were mean ± SD (n = 12) and expressed in mg/dL. The * indicates a significant difference compared with control group, *P < 0.05, **P < 0.01, ***P < 0.001. The # indicates a significant difference compared with model group, #P < 0.05, ##P < 0.01, ###P < 0.001. The † indicates a significant difference compared with PMR group (same dosage level, F compared with C, G compared to D, H compared to E), †P < 0.05, ††P < 0.01.
|